KLHL36
gene geneOn this page
Also known as FLJ12543
Summary
KLHL36 (kelch like family member 36, HGNC:17844) is a protein-coding gene on chromosome 16q24.1, encoding Kelch-like protein 36 (Q8N4N3). Probable substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Enables cullin family protein binding activity. Predicted to be involved in protein ubiquitination.
Source: NCBI Gene 79786 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 146 total
- MANE Select transcript:
NM_024731
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17844 |
| Approved symbol | KLHL36 |
| Name | kelch like family member 36 |
| Location | 16q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ12543 |
| Ensembl gene | ENSG00000135686 |
| Ensembl biotype | protein_coding |
| Entrez | 79786 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 12 protein_coding, 2 retained_intron
ENST00000258157, ENST00000325279, ENST00000564159, ENST00000564996, ENST00000565743, ENST00000567410, ENST00000569472, ENST00000861561, ENST00000861562, ENST00000861563, ENST00000923923, ENST00000949874, ENST00000949875, ENST00000949876
RefSeq mRNA: 2 — MANE Select: NM_024731
NM_001303451, NM_024731
CCDS: CCDS10948, CCDS76909
Canonical transcript exons
ENST00000564996 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001175192 | 84650852 | 84650930 |
| ENSE00001228516 | 84648511 | 84648649 |
| ENSE00001228526 | 84656871 | 84657944 |
| ENSE00003462776 | 84659760 | 84659917 |
| ENSE00003849168 | 84661578 | 84667686 |
Expression profiles
Bgee: expression breadth ubiquitous, 267 present calls, max score 94.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.3780 / max 223.1221, expressed in 1813 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 155335 | 18.3780 | 1813 |
Top tissues by expression
289 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| seminal vesicle | UBERON:0000998 | 94.64 | gold quality |
| cardia of stomach | UBERON:0001162 | 93.32 | gold quality |
| heart right ventricle | UBERON:0002080 | 93.05 | gold quality |
| adult organism | UBERON:0007023 | 92.86 | gold quality |
| renal medulla | UBERON:0000362 | 92.78 | gold quality |
| skin of hip | UBERON:0001554 | 92.69 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 92.28 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 92.11 | gold quality |
| oral cavity | UBERON:0000167 | 91.79 | gold quality |
| pylorus | UBERON:0001166 | 91.64 | gold quality |
| vena cava | UBERON:0004087 | 91.56 | gold quality |
| colonic mucosa | UBERON:0000317 | 91.51 | gold quality |
| superficial temporal artery | UBERON:0001614 | 91.51 | gold quality |
| corpus epididymis | UBERON:0004359 | 91.50 | gold quality |
| cerebellar vermis | UBERON:0004720 | 91.48 | gold quality |
| jejunal mucosa | UBERON:0000399 | 91.38 | gold quality |
| jejunum | UBERON:0002115 | 90.79 | gold quality |
| cauda epididymis | UBERON:0004360 | 90.70 | gold quality |
| parietal pleura | UBERON:0002400 | 90.69 | gold quality |
| parotid gland | UBERON:0001831 | 90.63 | gold quality |
| caput epididymis | UBERON:0004358 | 90.61 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 90.15 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 89.92 | gold quality |
| saphenous vein | UBERON:0007318 | 89.91 | gold quality |
| synovial joint | UBERON:0002217 | 89.84 | gold quality |
| body of tongue | UBERON:0011876 | 89.71 | gold quality |
| urethra | UBERON:0000057 | 89.63 | gold quality |
| mammary duct | UBERON:0001765 | 89.58 | gold quality |
| bronchial epithelial cell | CL:0002328 | 89.57 | gold quality |
| eye | UBERON:0000970 | 89.52 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.08 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
140 targeting KLHL36, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | klhl36 | ENSDARG00000030251 |
| mus_musculus | Klhl36 | ENSMUSG00000031828 |
| rattus_norvegicus | Klhl36 | ENSRNOG00000016422 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359), KLHL33 (ENSG00000185271)
Protein
Protein identifiers
Kelch-like protein 36 — Q8N4N3 (reviewed: Q8N4N3)
All UniProt accessions (4): Q8N4N3, H3BPB9, H3BQE9, H3BQW5
UniProt curated annotations — full annotation on UniProt →
Function. Probable substrate-specific adapter of an E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Subunit / interactions. Interacts with CUL3.
Pathway. Protein modification; protein ubiquitination.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N4N3-1 | 1 | yes |
| Q8N4N3-2 | 2 |
RefSeq proteins (2): NP_001290380, NP_079007* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
Pfam: PF00651, PF01344, PF07707, PF24681
UniProt features (13 total): repeat 6, domain 2, chain 1, compositionally biased region 1, splice variant 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N4N3-F1 | 91.36 | 0.81 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 104 (showing top):
MODULE_255, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, MODULE_317, TGACCTY_ERR1_Q2, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, AACTTT_UNKNOWN, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, TGACCTTG_SF1_Q6, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_TRANSFERASE_COMPLEX, LEIN_MEDULLA_MARKERS, MODULE_69, GOBP_PROTEOLYSIS, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX
GO Biological Process (1): protein ubiquitination (GO:0016567)
GO Molecular Function (2): cullin family protein binding (GO:0097602), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein modification by small protein conjugation | 1 |
| protein binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
686 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL36 | KIAA0513 | O60268 | 677 |
| KLHL36 | CIBAR2 | Q6ZTR7 | 626 |
| KLHL36 | DCLK2 | Q8N568 | 581 |
| KLHL36 | SLC15A5 | A6NIM6 | 571 |
| KLHL36 | SSMEM1 | Q8WWF3 | 447 |
| KLHL36 | CFAP77 | Q6ZQR2 | 447 |
| KLHL36 | OR4D1 | Q15615 | 436 |
| KLHL36 | REXO4 | Q9GZR2 | 403 |
| KLHL36 | TMEM121B | Q9BXQ6 | 397 |
| KLHL36 | FAM114A2 | Q9NRY5 | 350 |
| KLHL36 | IGDCC4 | Q8TDY8 | 345 |
| KLHL36 | CCDC14 | Q49A88 | 329 |
| KLHL36 | FBXW12 | Q6X9E4 | 324 |
| KLHL36 | DDRGK1 | Q96HY6 | 315 |
| KLHL36 | TMEM171 | Q8WVE6 | 313 |
IntAct
62 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| APEX1 | KLHL36 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HEXB | KLHL36 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KLHL36 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CUL3 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.530 |
| AAR2 | SNRNP200 | psi-mi:“MI:0914”(association) | 0.530 |
| ITM2A | NDUFB5 | psi-mi:“MI:0914”(association) | 0.530 |
| KLHL36 | HSPA8 | psi-mi:“MI:0914”(association) | 0.530 |
| EIF1AY | EIF1AX | psi-mi:“MI:0914”(association) | 0.530 |
| STEEP1 | KLHL36 | psi-mi:“MI:0914”(association) | 0.530 |
| CUL3 | ZSWIM8 | psi-mi:“MI:0914”(association) | 0.530 |
| HMGN2 | GBE1 | psi-mi:“MI:0914”(association) | 0.530 |
| GPS1 | PXDNL | psi-mi:“MI:0914”(association) | 0.530 |
| SLC6A15 | CLGN | psi-mi:“MI:0914”(association) | 0.530 |
| PDAP1 | KLHL36 | psi-mi:“MI:0915”(physical association) | 0.500 |
| PACRG | KLHL36 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SUN5 | KLHL36 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (67): KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS), KLHL36 (Affinity Capture-MS)
ESM2 similar proteins: A2AAX3, A2AUC9, B3DIV9, D2HEW7, D3ZA50, D3ZZC3, E9QJ30, G3X9X1, O14682, O35709, O60662, Q08BL9, Q0D2A9, Q1LYM6, Q2TBA0, Q2WGJ6, Q3B7M1, Q4KLM4, Q53GT1, Q56A24, Q5EB39, Q5RCQ9, Q5RDY3, Q5RGB8, Q5U504, Q5U575, Q5ZJU2, Q66HD2, Q6DEL7, Q6DFF7, Q6GQU2, Q6NYM1, Q6Q7X9, Q6TFL4, Q6V595, Q8BRG6, Q8BWA5, Q8CA72, Q8IY47, Q8N4N3
Diamond homologs: A0A0A6YY25, B2RXH4, E0CZ16, E1B932, E7F6F9, F1LZ52, F1LZF0, F1MBP6, O88282, O93567, O95198, P10074, P17789, P42282, P42283, P42284, Q01295, Q1H9T6, Q24174, Q24206, Q3B7M1, Q52KG4, Q53G59, Q53HC5, Q5R633, Q5REP9, Q5U374, Q66HD2, Q6NRH0, Q7KQZ4, Q7KRI2, Q867Z4, Q86B87, Q8BGY4, Q8BZM0, Q8CA72, Q8IN81, Q8JZP3, Q8K0L9, Q8N143
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
146 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 128 |
| Likely benign | 10 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
895 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:84648693:G:GT | donor_gain | 1.0000 |
| 16:84656865:GTCCA:G | acceptor_loss | 1.0000 |
| 16:84656866:TCCA:T | acceptor_loss | 1.0000 |
| 16:84656867:CCAG:C | acceptor_loss | 1.0000 |
| 16:84656868:CA:C | acceptor_loss | 1.0000 |
| 16:84656869:A:AT | acceptor_loss | 1.0000 |
| 16:84659867:GAC:G | donor_gain | 1.0000 |
| 16:84661567:C:A | acceptor_gain | 1.0000 |
| 16:84656869:A:AG | acceptor_gain | 0.9900 |
| 16:84656870:G:GG | acceptor_gain | 0.9900 |
| 16:84656870:GGT:G | acceptor_gain | 0.9900 |
| 16:84656870:GGTAT:G | acceptor_gain | 0.9900 |
| 16:84659754:CCACA:C | acceptor_loss | 0.9900 |
| 16:84659755:CACA:C | acceptor_loss | 0.9900 |
| 16:84659756:ACAGG:A | acceptor_loss | 0.9900 |
| 16:84659757:CA:C | acceptor_loss | 0.9900 |
| 16:84659759:G:A | acceptor_loss | 0.9900 |
| 16:84659867:G:GT | donor_gain | 0.9900 |
| 16:84659894:GTCC:G | donor_gain | 0.9900 |
| 16:84659895:TCCT:T | donor_gain | 0.9900 |
| 16:84659913:CCAAG:C | donor_loss | 0.9900 |
| 16:84659914:CAAGG:C | donor_loss | 0.9900 |
| 16:84659915:AAG:A | donor_loss | 0.9900 |
| 16:84659916:AGGT:A | donor_loss | 0.9900 |
| 16:84659917:GG:G | donor_loss | 0.9900 |
| 16:84659918:G:GC | donor_loss | 0.9900 |
| 16:84659919:T:A | donor_loss | 0.9900 |
| 16:84661560:T:TA | acceptor_gain | 0.9900 |
| 16:84661564:C:CA | acceptor_gain | 0.9900 |
| 16:84661574:GCAG:G | acceptor_loss | 0.9900 |
AlphaMissense
4038 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:84657936:T:A | W377R | 0.999 |
| 16:84657936:T:C | W377R | 0.999 |
| 16:84659781:C:A | R387S | 0.999 |
| 16:84659790:T:C | F390L | 0.999 |
| 16:84659792:C:A | F390L | 0.999 |
| 16:84659792:C:G | F390L | 0.999 |
| 16:84659892:T:A | W424R | 0.999 |
| 16:84659892:T:C | W424R | 0.999 |
| 16:84661631:G:A | G450E | 0.999 |
| 16:84661699:T:A | W473R | 0.999 |
| 16:84661699:T:C | W473R | 0.999 |
| 16:84661858:T:A | W526R | 0.999 |
| 16:84661858:T:C | W526R | 0.999 |
| 16:84657009:A:C | S68R | 0.998 |
| 16:84657011:C:A | S68R | 0.998 |
| 16:84657011:C:G | S68R | 0.998 |
| 16:84659833:G:A | G404D | 0.998 |
| 16:84659833:G:T | G404V | 0.998 |
| 16:84659836:G:C | R405P | 0.998 |
| 16:84661630:G:T | G450W | 0.998 |
| 16:84661634:G:A | G451D | 0.998 |
| 16:84661701:G:C | W473C | 0.998 |
| 16:84661701:G:T | W473C | 0.998 |
| 16:84661729:C:A | R483S | 0.998 |
| 16:84661730:G:C | R483P | 0.998 |
| 16:84661735:T:A | W485R | 0.998 |
| 16:84661735:T:C | W485R | 0.998 |
| 16:84661778:G:A | G499E | 0.998 |
| 16:84661781:G:A | G500D | 0.998 |
| 16:84661860:G:C | W526C | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000141679 (16:84651694 T>C), RS1000148983 (16:84663440 C>A,G,T), RS1000180647 (16:84663239 C>G,T), RS1000218197 (16:84649506 G>A), RS1000477222 (16:84653771 C>A,T), RS1000514496 (16:84664307 G>A), RS1000586433 (16:84658311 C>G,T), RS1000684906 (16:84666466 G>C), RS1000874256 (16:84656261 TTTTG>T,TTTTGTTTG), RS1000919570 (16:84662407 C>A,T), RS1001249811 (16:84666142 T>A), RS1001313149 (16:84651417 G>A,C), RS1001556826 (16:84649859 A>T), RS1001576901 (16:84667043 C>T), RS1001709386 (16:84654427 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000838_4 | Waist circumference | 4.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation | 3 |
| Tretinoin | increases expression | 2 |
| pirinixic acid | affects binding, increases activity, increases expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| nickel sulfate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | increases expression, affects cotreatment, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cisplatin | affects expression | 1 |
| Hydrogen Peroxide | increases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | increases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Asbestos, Serpentine | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.